title: Liver and bile duct pathology following Cryptosporidium parvum infection of immunodeficient mice.
abstract: Patients with acquired immune deficiency syndrome (AIDS) and boys with mutations of the CD154 gene (causing congenital X-linked immunodeficiency with hyper-IgM [XHIM]) are susceptible to chronic infections of the biliary tract with Cryptosporidium parvum (CP) that may lead to biliary sclerosis and ultimately to cholangiocarcinoma. To determine whether the CP infection and the consequent immune response contribute independently to this morbidity, we infected mice with severe combined immunodeficiency (SCID) or with disrupted genes for CD154, CD40, or interferon gamma (IFN-gamma) with CP. Even when CP infection persisted for 16 weeks, the SCID mice developed only mild triaditis, without apoptosis of biliary epithelial cells (BEC). Fifty percent of the CD154 knockout mice developed lobular hepatitis with acute and chronic triaditis. The CD40 knockout mice developed marked triaditis, and the IFN-gamma knockouts either succumbed to enteritis or survived to develop marked triaditis, portal fibrosis, biliary sclerosis, necrosis with dilation of duct-like structures within the porta hepatis, and dysplastic changes. CP-infected SCID mice reconstituted with T cells from IFN-gamma knockout donors either developed severe enteritis or survived to develop triaditis, cholangitis, lobular hepatitis with periductular sclerosis, and scarring. Mice with disruptions of both the CD40 and IFN-gamma genes remained infected by CP and developed bile duct and liver disease, but not enteritis. Our results suggest that T-cell cytokines are required for the inflammatory and sclerosing responses to CP infection in immunodeficient animals. The response of immunodeficient mice to CP infection may model at least the initial steps toward the development of sclerosing cholangitis or bile duct cancers in XHIM patients.
authors.affiliation: Departments of Pathology, Pediatrics, Immunology, and the Barbara Davis Childhood Diabetes Center, University of Colorado Health Sciences Center, Denver, CO, USA.
authors.forename: J
authors.initials: J
authors.lastname: Stephens
authors.forename: M
authors.initials: M
authors.lastname: Cosyns
authors.forename: M
authors.initials: M
authors.lastname: Jones
authors.forename: A
authors.initials: A
authors.lastname: Hayward
mesh_terms: D000818:Animals; D001652:Bile Ducts / Q000473:pathology*; D019013:CD40 Antigens / Q000235:genetics / Q000276:immunology; D023201:CD40 Ligand; D003457:Cryptosporidiosis / Q000276:immunology* / Q000473:pathology*; D016785:Cryptosporidium parvum; D007249:Inflammation; D007371:Interferon-gamma / Q000172:deficiency / Q000235:genetics / Q000276:immunology; D008099:Liver / Q000473:pathology*; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000235:genetics / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D016513:Mice, SCID; D012598:Sclerosis; D013997:Time Factors
chemical_list: D019013:CD40 Antigens; D008562:Membrane Glycoproteins; D023201:CD40 Ligand; D007371:Interferon-gamma